Fralin Biomedical Research Institute Spinoff Company Partnering With UVA Health to Improve Screening for Opioid Use Disorder
September 20, 2023
September 20, 2023
ROANOKE, Virginia, Sept. 20 (TNSres) -- The Fralin Biomedical Research Institute at Virginia Tech issued the following news:
BEAM Diagnostics Inc. -- a behavioral health company that sprung from research from Virginia Tech's Fralin Biomedical Research Institute at VTC -- has been awarded a $1.84 million grant from the National Institutes of Health (NIH) to commercialize its technology to improve assessment of opioid use disorder (OUD) in outpatient medical clinics, according to . . .
BEAM Diagnostics Inc. -- a behavioral health company that sprung from research from Virginia Tech's Fralin Biomedical Research Institute at VTC -- has been awarded a $1.84 million grant from the National Institutes of Health (NIH) to commercialize its technology to improve assessment of opioid use disorder (OUD) in outpatient medical clinics, according to . . .